Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion in Patients with Prior Treatment with Bevacizumab or Ranibizumab

被引：0
|
作者：
van Zyl, Tave [1 ]
Papakostas, Thanos D. [1 ]
Lim, Laurence Shen [1 ,2 ]
Miller, John B. [1 ]
Husain, Deeba [1 ]
Eliott, Dean [1 ]
Kim, Leo A. [1 ]
机构：
[1] Massachusetts Eye & Ear Infirm, Ophthalmol, Boston, MA 02114 USA
[2] Singapore Natl Eye Ctr, Ophthalmol, Singapore, Singapore
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2015年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4623
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
    T D Papakostas
    L Lim
    T van Zyl
    J B Miller
    B S Modjtahedi
    C M Andreoli
    D Wu
    L H Young
    I K Kim
    D G Vavvas
    D D Esmaili
    D Husain
    D Eliott
    L A Kim
    [J]. Eye, 2016, 30 : 79 - 84
  • [2] Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
    Papakostas, T. D.
    Lim, L.
    van Zyl, T.
    Miller, J. B.
    Modjtahedi, B. S.
    Andreoli, C. M.
    Wu, D.
    Young, L. H.
    Kim, I. K.
    Vavvas, D. G.
    Esmaili, D. D.
    Husain, D.
    Eliott, D.
    Kim, L. A.
    [J]. EYE, 2016, 30 (01) : 79 - 84
  • [3] Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
    Alex Yuan
    Baseer U.Ahmad
    David Xu
    Rishi P.Singh
    Peter K.Kaiser
    Daniel F.Martin
    Jonathan E.Sears
    Andrew P.Schachat
    Justis P.Ehlers
    [J]. International Journal of Ophthalmology, 2014, 7 (01) : 86 - 91
  • [4] Aflibercept versus bevacizumab and/or ranibizumab for recurrent macular edema secondary to central retinal vein occlusion
    Dedania, Vaidehi
    Ozgonul, Cem
    Besirli, Cagri G.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [5] Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion
    Ozgonul, Cem
    Dedania, Vaidehi S.
    Besirli, Cagri G.
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (04) : 340 - 345
  • [6] Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
    Yuan, Alex
    Ahmad, Baseer U.
    Xu, David
    Singh, Rishi P.
    Kaiser, Peter K.
    Martin, Daniel F.
    Sears, Jonathan E.
    Schachat, Andrew P.
    Ehlers, Justis P.
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2014, 7 (01) : 86 - 91
  • [7] INTRAVITREAL RANIBIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
    Risard, Sarah M.
    Pieramici, Dante J.
    Rabena, Melvin D.
    Basefsky, Jessica C.
    Avery, Robert L.
    Castellarin, Alessandro A.
    Nasir, Ma'an A.
    See, Robert F.
    Couvillion, Stephen S.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (06): : 1060 - 1067
  • [8] EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
    Lotfy, Ayman
    Solaiman, Kamal A. M.
    Abdelrahman, Ayman
    Samir, Ahmed
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (09): : 1795 - 1800
  • [9] Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’
    T D Papakostas
    D Vavvas
    D Eliott
    L A Kim
    [J]. Eye, 2016, 30 : 766 - 767
  • [10] Reply to 'Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab'
    Papakostas, T. D.
    Vavvas, D.
    Eliott, D.
    Kim, L. A.
    [J]. EYE, 2016, 30 (05) : 766 - 767
12345